Literature DB >> 1395068

Serum levels of growth hormone-binding protein and insulin-like growth factor-I during puberty.

G Massa1, R Bouillon, M Vanderschueren-Lodeweyckx.   

Abstract

OBJECTIVE: The aim was to investigate the effect of pubertal development on serum levels of growth hormone binding protein (GHBP) and IGF-I, and to study the relationship between GHBP levels and height standard deviation score (SDS), nutritional state and IGF-I levels. DESIGN AND PATIENTS: The investigation was performed on serum samples from 72 healthy adolescents of different pubertal stage. Results were compared to those obtained in 46 prepubertal children. MEASUREMENTS: Serum levels of GHBP were measured by HPLC gel filtration and IGF-I levels were measured by RIA after acid-ethanol extraction.
RESULTS: No effect of pubertal stage on serum levels of GHBP was found. A positive relationship was found between serum levels of GHBP and height SDS (r = 0.38; P < 0.005) and weight expressed as percentage of median weight for height age (r = 0.46; P < 0.0005). Serum levels of IGF-I increased during puberty and were not correlated with height SDS or weight for height age. In pubertal subjects, no relationship existed between serum levels of GHBP and IGF-I. In prepubertal subjects, however, a significantly positive relationship between GHBP and IGF-I levels (r = 0.66; P < 0.0005) was found.
CONCLUSIONS: Pubertal development does not seem to influence serum levels of GHBP. Height SDS and nutritional state are related to the concentration of GHBP. Before puberty, the level of GHBP is positively related to IGF-I levels; during puberty, however, the increase in serum IGF-I levels is not accompanied by changes in the amount of circulating GHBP.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1395068     DOI: 10.1111/j.1365-2265.1992.tb02303.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  6 in total

Review 1.  Circulating growth hormone binding proteins.

Authors:  G Baumann; M A Shaw; K Amburn
Journal:  J Endocrinol Invest       Date:  1994-01       Impact factor: 4.256

2.  Relation between insulin-like growth factor-I, body mass index, and clinical status in cystic fibrosis.

Authors:  A M Taylor; A Bush; A Thomson; P J Oades; J L Marchant; C Bruce-Morgan; J Holly; L Ahmed; D B Dunger
Journal:  Arch Dis Child       Date:  1997-04       Impact factor: 3.791

3.  Serum growth hormone-binding protein is decreased in prepubertal children with idiopathic short stature.

Authors:  N Dávila; M Moreira-Andrés; J Alcañiz; B Barceló
Journal:  J Endocrinol Invest       Date:  1996-06       Impact factor: 4.256

4.  Serum levels of growth hormone-binding protein and insulin-like growth factor I in children and adolescents with type 1 (insulin-dependent) diabetes mellitus.

Authors:  G Massa; L Dooms; R Bouillon; M Vanderschueren-Lodeweyckx
Journal:  Diabetologia       Date:  1993-03       Impact factor: 10.122

5.  Growth hormone binding protein activity in obese children.

Authors:  S Seminara; A Filpo; F La Cauza; A Faedda; A Miola; S Pellizzone; M Casati; S Loche
Journal:  J Endocrinol Invest       Date:  1998 Jul-Aug       Impact factor: 4.256

6.  The association of breast mitogens with mammographic densities.

Authors:  N F Boyd; J Stone; L J Martin; R Jong; E Fishell; M Yaffe; G Hammond; S Minkin
Journal:  Br J Cancer       Date:  2002-10-07       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.